168 related articles for article (PubMed ID: 33469928)
1. Cutaneous involvement as initial presentation of multicentric plasmacytic Castleman disease.
Chen H; Ba W; Chen H; Yang H
J Cutan Pathol; 2021 May; 48(5):701-705. PubMed ID: 33469928
[TBL] [Abstract][Full Text] [Related]
2. Hyaline vascular variant of unicentric Castleman disease of the tonsil: a case report.
Li P; Liu H; Li H; Li A; Yu G; Yin W
Diagn Pathol; 2019 Jun; 14(1):70. PubMed ID: 31253137
[TBL] [Abstract][Full Text] [Related]
3. Multicentric Castleman disease of hyaline vascular variant presenting with unusual systemic manifestations: a case report.
Basnayake BMDB; Wazil AWM; Kannangara T; Ratnatunga NVI; Hewamana S; Ameer AM
J Med Case Rep; 2017 May; 11(1):135. PubMed ID: 28501028
[TBL] [Abstract][Full Text] [Related]
4. Historical and pathological overview of Castleman disease.
Nishimura MF; Nishimura Y; Nishikori A; Yoshino T; Sato Y
J Clin Exp Hematop; 2022 Jun; 62(2):60-72. PubMed ID: 35474035
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and treatment outcomes of Castleman disease in children: a retrospective cohort in China.
Hu S; Li Z; Wang H; Chen L; Ma Y; Zhu X; Li J; Dong R; Yao W; Dong C; Zhang H; Li K; Dong K; Zhai X
Eur J Pediatr; 2023 Dec; 182(12):5519-5530. PubMed ID: 37782352
[TBL] [Abstract][Full Text] [Related]
6. Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman disease.
Nabel CS; Sameroff S; Shilling D; Alapat D; Ruth JR; Kawano M; Sato Y; Stone K; Spetalen S; Valdivieso F; Feldman MD; Chadburn A; Fosså A; van Rhee F; Lipkin WI; Fajgenbaum DC
PLoS One; 2019; 14(6):e0218660. PubMed ID: 31242229
[TBL] [Abstract][Full Text] [Related]
7. A Rare Lymphoproliferative Disease: Castleman Disease.
Gündüz E; Özdemir N; Bakanay ŞM; Karakuş S
Turk J Haematol; 2021 Dec; 38(4):314-320. PubMed ID: 34719151
[TBL] [Abstract][Full Text] [Related]
8. Localized Plaques on the Scalp as Initial Presentation of Multicentric Plasmacytic Castleman Disease.
Zhang H; Li K; Zhang J; Chen X
Clin Cosmet Investig Dermatol; 2022; 15():1833-1836. PubMed ID: 36105750
[TBL] [Abstract][Full Text] [Related]
9. Human Herpesvirus Type 8-positive Multicentric Castleman Disease.
Melikyan AL; Egorova EK; Julhakyan HL; Kovrigina AL; Savchenko VG
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S159-65. PubMed ID: 27133959
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous Plasmacytosis and Idiopathic Multicentric Castleman Disease: A Spectrum of Disease?
Drissi M; Dunlap R; Clayton L; Raess PW; Mengden Koon S; White K
Am J Dermatopathol; 2022 Apr; 44(4):294-296. PubMed ID: 34966045
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of Castleman Disease.
Szalat R; Munshi NC
Hematol Oncol Clin North Am; 2018 Feb; 32(1):53-64. PubMed ID: 29157619
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease.
Lurain K; Yarchoan R; Uldrick TS
Hematol Oncol Clin North Am; 2018 Feb; 32(1):75-88. PubMed ID: 29157621
[TBL] [Abstract][Full Text] [Related]
13. Imaging of Castleman Disease.
Pitot MA; Tahboub Amawi AD; Alexander LF; LeGout JD; Walkoff L; Navin PJ; Kawashima A; Wood AJ; Dispenzieri A; Venkatesh SK
Radiographics; 2023 Aug; 43(8):e220210. PubMed ID: 37471247
[TBL] [Abstract][Full Text] [Related]
14. Hyaline Vascular Type of Unicentric Castleman Disease in a Kidney with End-Stage Renal Disease: A Case Report of a Rare Entity at an Unusual Location and a Special Clinical Setting.
Chen CH; Li HN
Diagnostics (Basel); 2022 Nov; 12(11):. PubMed ID: 36428938
[TBL] [Abstract][Full Text] [Related]
15. Castleman Disease: A Multicenter Case Series from Turkey.
Gündüz E; Kırkızlar HO; Ümit EG; Karaman Gülsaran S; Özkocaman V; Özkalemkaş F; Candar Ö; Elverdi T; Küçükyurt S; Paydaş S; Çeneli Ö; Karakuş S; Maral S; Ekinci Ö; İpek Y; Kis C; Güven ZT; Akdeniz A; Celkan T; Eroğlu Küçükdiler AH; Akgün Çağlıyan G; Özçelik Şengöz C; Karataş A; Bulduk T; Özcan A; Belen Apak FB; Canbolat A; Kartal İ; Ören H; Töret E; Özdemir GN; Bakanay Öztürk ŞM
Turk J Haematol; 2022 Jun; 39(2):130-135. PubMed ID: 35176839
[TBL] [Abstract][Full Text] [Related]
16. [Not Available].
Bertinchamp R; Terriou L
Rev Med Interne; 2022 Dec; 43(10S1):10S4-10S9. PubMed ID: 36657941
[TBL] [Abstract][Full Text] [Related]
17. Castleman's disease: a study of a rare lymphoproliferative disorder in a university hospital.
Al-Amri AM; Abdul-Rahman IS; Ghallab KQ
Gulf J Oncolog; 2010 Jan; (7):25-36. PubMed ID: 20164006
[TBL] [Abstract][Full Text] [Related]
18. Castleman disease in pediatrics: Insights on presentation, treatment, and outcomes from a two-site retrospective cohort study.
Sopfe J; Endres A; Campbell K; Hayes K; Trout AT; Liang X; Lorsbach R; O'Brien MM; Cost CR
Pediatr Blood Cancer; 2019 May; 66(5):e27613. PubMed ID: 30680887
[TBL] [Abstract][Full Text] [Related]
19. Treatment of multicentric Castleman disease through combination of tocilizumab, lenalidomide and glucocorticoids: Case report.
Cai S; Zhong Z; Li X; Wang HX; Wang L; Zhang M
Medicine (Baltimore); 2019 Nov; 98(46):e17681. PubMed ID: 31725610
[TBL] [Abstract][Full Text] [Related]
20. Next-generation sequencing of idiopathic multicentric and unicentric Castleman disease and follicular dendritic cell sarcomas.
Nagy A; Bhaduri A; Shahmarvand N; Shahryari J; Zehnder JL; Warnke RA; Mughal T; Ali S; Ohgami RS
Blood Adv; 2018 Mar; 2(5):481-491. PubMed ID: 29496669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
